Biotech IV Monitor

VCYT — Veracyte Inc.

$4.5B market cap · 0 upcoming readouts tracked

Clinical trial readout dates for Veracyte Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced.

Market cap$4.5B
Cash & investments$200Mas of Sep 30, 2026
Recent 8-K filings1latest 2026-11-04

In progress, no date published

Phase 3 NRG/RTOG 0521
Prostate cancer
date not published
Ongoing

Cash position

Veracyte Inc. reported $200M in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-05). It reported net income of $32M for that quarter.

Recent SEC filings

8-K Other Events — often topline trial data2026-11-04

Companies working on similar indications

Discussion

No messages yet. If you follow VCYT, you can start the conversation.
Track VCYT in real time
See live implied volatility for VCYT and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on VCYT
Contact — questions or corrections about VCYT: dukeupt@gmail.com